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Abstract: Prostate cancer (PCa) is the second leading cause of
death among men in Europe and U.S. The metastatic dissemina-
tion pattern of PCa is unique, developing bone metastasis as the
only site of progression, consequently with a prognosis very
poor. The cancer cells interactions within the surrounding bone
environment are critical for tumor growth and progression.
Secreted protein, acidic and rich in cysteine (SPARC) is described
to be involved in PCa cells migration and invasion into bone.
Three-dimensional (3D) in vitro systems that are able to closely
resemble the in vivo microenvironment are recently taking impor-
tance in cancer research. Original nanohydroxyapatite/collagen
scaffolds were designed to resemble bone microenvironment in
order to be applied as substitutes in bone defects and as potential
biomaterials to mimic skeletal tumors. In fact, these 3D structures
were cytocompatible and able to support osteoblast (MC3T3-E1)
colonization and to promote bone ingrowth. Additionally, SPARC 
adsorption onto the scaffolds affected PC3 and LNCaP PCa cell 
lines behavior. PC3 cells were found to adapt and colonize the 
scaffolds, differing from LNCaP where cells underwent morpho-
genic changes and grew as clusters. Furthermore, for the tested 
SPARC concentration, SPARC plays a role in retaining LNCaP 
cells at the latter time points while with PC3 cells no significant 
differences were observed. This characterization study is required 
to establish a bone model to provide new insights into the poorly 
understood PCa mechanisms of metastasis to bone and the gen-
eration of improved therapies. 
Key Words: nanohydroxyapatite/collagen scaffold, tumor 3D
model, SPARC, prostate cancer, bone metastasis, MC3T3-E1
INTRODUCTION
Prostate cancer (PCa) has become the second leading cause of
death among men both in Europe and in United States.1 Each
year, around 220,000 American men are diagnosed with PCa
and 29,000 die from this pathology.2 Most deaths from PCa are
caused by widespread metastasis, in which bone is the prefer-
ential site of progression (60–70%).3 Bone metastases are com-
monly found in the vertebrae, pelvis, ribs, sternum, femur and
skull; its complications include pain, increased risk of facture,
hypercalcemia, and a decreased blood cell count. The prognosis
of cancers that metastasize to bone is in general very poor and
the treatment for bone metastases tends to minimize the symp-
toms by reducing pain and the risk of fracture.4 Reciprocal
interactions between PCa cells and bone cells result in a selec-
tive advantage for tumor growth leading to bone destruction or
new bone matrix deposition.5 The process of PCa metastasis to
bone can be described by the “seed and soil,” and/or by the
mechanical (or hemodynamic) mechanism theories.6
Koeneman et al. proposed that bone is a highly protective
and restricted environment inhibiting the growth and survival
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of cancerous cells and in order to thrive in the bone microenvir-
onment, these cells must acquire osteomimetic properties.7
Bone extracellular matrix is constituted essentially by hydroxy-
apatite (HA) crystals [Ca10(PO4)6(OH)2], along with collagen
(mainly type I), and noncollagenous proteins, such as secreted
protein, acidic and rich in cysteine (SPARC). The glycoprotein
SPARC belongs to a family of small, calcium and collagen bind-
ing proteins. SPARC is synthesized by different cell types,
namely osteoblasts, fibroblasts, endothelial cells, vascular
smooth muscle cells, and tumor cells.8,9 SPARC displays onco-
genic properties in many tumor types, highlighting the carci-
noma of the prostate.10,11 Jacob et al. suggested that specific
homing factors present in bone facilitate the growth of PCa
cells, in which SPARC may be responsible for chemotaxis of PCa
cells to bone.12 However, published data on the role of SPARC
during tumorigenesis are inconsistent and often conflicting,
even among the same tumor types, both in clinical correlative
studies and in animal models. It appears that the capacity of
SPARC to promote or inhibit tumor progression is dependent
on the cell-type, tumor-type and stage, and the specific context
of the tumor microenvironment.10,11,13 At present, a number of
studies involving PCa lines cultured on biomaterials have been
published in order to study tumorigenesis in vitro on prostate
cancer cells.14–18 Yet the development of a new three-
dimensional (3D) culture model that recreates bone native
tumor microenvironment and at the same time has the ability
to be easily functionalized with active agents (SPARC) might be
a valid strategy to understand the involvement of SPARC in
bone metastization.
This work describes the use of an engineered bone
biomimetic 3D model to enhance our understanding upon
the role of SPARC in PCa bone metastasis. This model
helped to explore innate PCa cell behavior in the biomimetic
structural and spatial configuration of bone. In addition, by
understanding the nature of cellular interactions between
PCa and bone microenvironment, it may be possible to
develop novel therapeutic approaches for the prevention
and treatment of PCa bone metastasis, since one of the
principles of bone targeting in neoplastic disease is to break
the cycle of cancer-bone interactions.19
MATERIALS AND METHODS
Scaffolds preparation
NanoHA scaffolds. The scaffolds were produced through
the already described polyurethane (PU) sponge impregna-
tion method.20 The flexible PU sponges (Recticel) were cut
into a cylindrical shape using a pneumatic hole punch. The
ceramic slurry was prepared using the nanoHA powder
(NanoXIM HAp202, Fluidinova, Portugal), ultrapure water
and a dispersing agent (Dolapix CE-64, Zschimmer &
Schwarz), in a ratio of 5.6: 4.4: 0.2 (w/v), respectively. The
samples were submitted to the following heat-treating cycle:
heating to 6008C at a heating rate of 18C/min, followed by
1 h plateau at 6008C; heating from 6008C to 8308C
(48C/min) followed by 1 h plateau at 8308C, finally the cycle
was completed with natural cooling inside the furnace
(Thermolab).
Preparation of the collagen solution. Insoluble type I
collagen from bovine Achilles tendon (Sigma-Aldrich,
C9879) was swollen in 0.01M hydrochloric acid (HCl)
solution. Using an Ultra-Turrax T25 (IKA, Germany), the
dispersion was homogenized for 3 h at 10,000 rpm, the
temperature was kept bellow 48C. Several collagen
concentrations were tested, namely 0.50%, 0.25%, 0.15%,
0.10%, and 0.05% (w/v).
NanoHA/collagen scaffolds. NanoHA scaffolds were
immersed in type I collagen solution and taken to a vacuum
oven (Binder) for 48 h at room temperature (RT). As cross-
linking agents 7.24 mM of N-hydroxysuccinimide (NHS,
Fluka, BioChemika) and 14.8 mM of N-(3-dimethylamino-
propyl)-N’-ethylcarbodiimide hydrochloride (EDC, Fluka,
BioChemika) were used. The crosslinking was performed in
2-morpholinoethane sulfonic acid (MES buffer, 0.05M,
Sigma), to minimize the hydrolysis of EDC.21,22 NanoHA/col-
lagen scaffolds were immersed in the freshly prepared
crosslinking solution for 2 h at 48C. Afterwards, the scaffolds
were washed three times with MES buffer.
Scaffolds characterization
Scanning electron microscopy (SEM). The SEM/EDS
analysis was performed using a High resolution (Schottky)
Scanning Electron Microscope with X-Ray Microanalysis and
Electron Backscattered Diffraction analysis (Quanta 400 FEG
ESEM/EDAX Genesis X4M). Scaffolds were mounted in SEM
sample holders using epoxy glue (Araldite). Samples were
coated with a gold/palladium (Au/Pd) thin film obtained by
90 to 110 s exposure, by sputtering, using the SPI Module
Sputter Coater equipment.
Attenuated total reflectance-Fourier transform infrared
(ATR-FTIR). ATR-FTIR was carried out using a Perkin Elmer
2000 FTIR/RAMAN spectrometer (Wellesley). The samples
were mounted on an ATR accessory named Split Pea (Har-
rick Scientific Corporation) supplied with a silicon hemi-
spherical crystal. The analyzed samples were the scaffolds
(nanoHA and nanoHA/collagen), the crosslinked collagen
fibers, as well as the sintered nanoHA powder. Chemical
characterization was done at a spectral resolution of 4 cm21
on a frequency region of 400 to 4000 cm21 and 100 scans
were accumulated per sample.
Microcomputed tomography (micro-CT). The samples
were further characterized by micro-CT analysis using a
SKYSCAN 1072 (Skyscan, Kontich, Belgium) equipment. The
scaffolds were scanned in high-resolution mode of 6.69 mm
x/y/z, where the ROI (region of interest) analyzed was 300
slices, which corresponds to approximately 2 mm height.
The scanner operated at 57 kV and a tube current of 175
mA. The scanned specimen’s representative data was con-
verted into binary images using a lower and upper gray
threshold of 70 and 255 respectively (70 to determine the
porosity and 255 to identify the apatite content along the
scaffold, therefore distinguishing material from pore voids).
The described operating parameters were kept constant for
all the samples. The sliced 2D tomographic raw images
were processed using CT Analyzer v.1.12.0.0 (SkyScan) and
3D virtual models of the scaffolds were created using
(CTVox, SkyScan).
SPARC quantification by radioactivity. A 125I radiolabelling
assay was performed to quantify the SPARC (125I-SPARC)
adsorbed on nanoHA/collagen samples. To perform this
experiment, porous granules of nanoHA/collagen (20 mg
per replica) were obtained from nanoHA/collagen scaffolds,
by carefully crushing and sieving the scaffolds (sizes of
granules obtained from 1.18 mm to 1.70 mm).
The SPARC used is from human source (Sigma,
SRP3159) used at a concentration of 10 lg/mL (which is
the concentration of the SPARC solution used in cell culture
later on). The quantification of SPARC adsorbed on granules
of nanoHA/collagen was accomplished with 125I labeled
SPARC (125I-SPARC) using the Iodogen method, and purified
using a Sephadex G-25 column (PD-10 column, Amersham
Biosciences), to remove unbound 125I.23,24 Previous to the
protein adsorption assays the granules were equilibrated
overnight at RT, in degased PBS with 0.01M NaI (PBSI) to
prevent adsorption of free 125I ions present in trace
amounts in 125I-SPARC. The contribution of free 125I to the
total radioactivity found on the scaffolds surfaces was
estimated using unlabeled SPARC solutions (with a final
concentration of 10 lg/mL) and an amount of free 125I ion
equivalent to that present as 125I ion in the labeled protein
solutions.
For the adsorption experiments, the SPARC solution was
prepared adding 125I-SPARC to unlabelled SPARC to obtain
solutions with a desired final activity of about 106 cpm/mL.
The nanoHA/collagen granules were incubated in a
125I-SPARC solution during 60 min at 258C. To assess the
influence of the rinsing procedure the gamma countings of
the samples were measured before and after the granules
were rinsed 33 in phosphate buffered saline (PBS, Sigma,
pH57.4) (500 lL). At the end of the immersion time in
PBS (48 h) the samples were rinsed 33 with PBS, and then
transferred to radioimmunoassay tubes (RIA) with 500 lL
of PBS and surface activity was measured using a gamma
counter (Wallac Wizard, model 1470). The rinsing
procedure was performed in order to remove both free
iodine and non-adsorbed protein.
The counts were averaged, and the surface concentration
was calculated by the following Eq. (1):
SPARC lg=m2
 
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where the counts represent the gamma activity of the sam-
ples, SPARCsolution is the specific gamma activity of the
SPARC solution expressed in counts per mL of solution,
|SPARC| is the concentration of SPARC solution and SA
stands for the actual surface area of the granules, which
was determined by micro-CT.23,25
In vitro biological studies
The MC3T3-E1 cells are derived from a pre-osteoblastic cell
line from normal mouse calvaria. The PC3 cells (androgen
independent) are derived from a human PCa bone metasta-
sis, whereas LNCaP cells (androgen sensitive) are derived
from a human PCa lymph node metastasis (American Type
Tissue Collection, ATCC), kindly provided by Portuguese
Oncology Institute, Porto, Portugal.
Maintenance of MC3T3-E1, PC3, and LNCaP cell lines.
MC3T3-E1 cells were grown in a-minimum essential
medium (a-MEM, Gibco), supplemented with 10% fetal
bovine serum [(FBS), Invitrogen] and 1% penicillin/
streptomycin [(P/S) (Gibco)]. The PC3 and LNCaP cell lines
were maintained in 50% RPMI 1640 and 50% Ham’s F-12
Nutrient Mix (v/v) (Gibco, Invitrogen) and in RPMI 1640,
respectively. Both media were supplemented with 10%
(v/v) FBS Heat inactivated (Gibco, Invitrogen) and 1% P/S.
Cells were incubated in a humidified incubator (378C and
5% CO2). The culture medium was replaced three times a
week.
Cell cultures and SPARC adsorption on the scaffolds. To
perform the in vitro biological studies the scaffolds were
sterilized by immersion in a 70% ethanol solution (v/v) for
4 h, and incubated with the corresponding medium (not
supplemented) overnight. The porous structures were incu-
bated with the SPARC solution (10 mg/mL) during 60 min
at RT. Subsequently cells were seeded on the structures in
commercial 96-well cell culture plates, at a cell seeding den-
sity of 1 3 105 cells/well for MC3T3-E1 and PC3, and 6.5
3 105 cells/well for LNCaP. The medium was changed three
times a week. For each material and cell line, six replicates
were established for the resazurin assay. Control cultures
were done on tissue culture polystyrene (TCPS) undergoing
the same conditions as the scaffolds.
Metabolic activity. For this assay, 10% (v/v) of fluorescent
dye (R7017, Sigma) was added to the cell medium, includ-
ing controls, and incubated at 378C in a humidified atmos-
phere of 5% CO2 for 4 h. Then 100 mL of the solution were
collected and transferred into a black 96-well plate and flu-
orescence intensity was measured by a fluorescence reader
(SynergyMx, BioTek) using Gen5 1.09 software at k5 530
and k5590 nm for excitation and emission, respectively.
Statistical analysis. The experimental results were statisti-
cally analyzed by one-way ANOVA, followed by post hoc Tukey
test using Statistical Package for Social Sciences (SPSS)
version 21 (IBM). The values were considered statistically
significant when p< 0.05.
Confocal laser scanning microscopy (CLSM). Cell-seeded
samples were fixed with 4% paraformaldehyde (PFA) for 15
min. Cells were therefore permeabilized with 0.1% Triton
X-100 and incubated in 1% bovine serum albumin (BSA)
for 30 min at 378C. The cytoskeletal F-actin filaments of
the cell were stained with Alexa Fluor 594 Phalloidin
(1:100, Molecular Probes A12381, Invitrogen) in 1% BSA
during 30 min in the dark at RT. The nuclei of cells were
counterstained with Hoechst 33342 (H1399, Life Tech) in
PBS during 15 min in the dark at RT. The scaffolds were
mounted in a proper dish (Ø 35 mm). Images were acquired
by using a Leica SP5 Confocal microscope with 203 oil
objective, and processed with Leica Application Suite Ver-
sion 2.6.0.
SEM analysis of cell-seeded scaffolds. Cells were fixed using
a solution of 1.5% gluteraldehyde (v/v) (Agar) in 0.14M
sodium cacodylate buffer (Merck) for 30 min at RT. After-
wards the samples were dehydrated by immersion in a serial
of graded ethanol solutions for 10 min in each. The final step
consisted in adding hexamethyldisilazane (Sigma) to each
well and let the scaffolds dry. The samples were mounted like-
wise as in Scanning electron microscopy (SEM) section.
RESULTS
Physical, morphological, and chemical characterization
of the porous scaffolds
Using the PU sponge impregnation method it was possible
to produce highly porous hydroxyapatite scaffolds in a cylin-
drical shape with 2.3460.29 mm height and 5.336
0.19 mm of diameter.
Scanning electron microscopy (SEM). The nanoHA powder
used to produce the macroporous scaffolds was originally in
the form of nanoparticles aggregates with a spherical
morphology, which was preserved during the sintering cycle,
as depicted in Figure 1. These structures presented macropore
diameters of approximately 326.23678.10 lm, micropores
and nanopores with dimensions around 46.506 6.67 nm were
found at higher magnifications. The preparation of the
nanoHA/collagen scaffolds involved the evaluation of the most
suitable collagen concentration. Therefore, Therefore, the low-
est collagen concentration of 0.05% was more adequate due to
the formation of collagen fibers without fully covering the
nanoHA surface as it happened with the other collagen concen-
trations used (0.50%, 0.25%, 0.15% and 0.10%). Additionally,
it may be observed in Figure 1 that the distribution of the
0.05% collagen fibers was heterogeneous. Nonetheless the
collagen fibers, as well as the nanoHA surface, are both well
exposed for cell-surface interactions as in bone.
Attenuated total reflectance-Fourier transform infrared
(ATR-FTIR). The ATR-FTIR spectra for all the samples con-
taining nanoHA are represented in Figure 2. The bands
appearing at 630 and 3572 cm21 were due to the vibrational
and stretching mode of hydroxyl ions (OH–) during the sinter-
ing cycle. The well-defined peaks at 564 and 600 cm21 were
attributed to the bending vibration of PO3–4 . The characteris-
tics bands of carbonate ions (present at 882, 1421, and
1460 cm21) have not been detected. This suggests that no car-
bonate substitution in nanoHA particles occurred after being
exposed to high temperature during the sintering cycle.26
The main bands of the collagen fingerprint at 1661 to
1640 cm21 are attributed to amide I (carbonyl stretching –
C@O), at 1549 cm21 is associated to amide II (due to the vibra-
tions in the plane of C-N stretching and N-H bending), and at
FIGURE 1. SEM images of porous scaffolds obtained by the PU impregnation method. In the top left image it may be observed macropores and
pore interconnectivity. In the top middle image, the spherical aggregates morphology present in the nanoHA powder were preserved during the
sintering cycle and the aggregates were bond through small contact areas. In the top right image is perceptible the nano-sized porosity and its
magnification. The SEM images (down) taken in several areas of nanoHA scaffolds with 0.05% collagen crosslinked with EDC/NHS.
1234 to 1228 cm21, the band corresponds to the vibrations in
the plane of amide III (C-N stretching and N-H bending).27
Micro-CT. Further morphological analysis of the nanoHA
macroporous scaffolds was performed using micro-CT, in
which 3D representations and micro-CT video were
obtained (Supporting Information Figure S1 and micro-CT
video of the Supporting Information). The mean macro-
porosity obtained was 62.4061.76%, the respective mean
pore size was 367.0265.79 lm, and the actual surface area
was 1936 2 mm2. Micro-CT analysis provided more accu-
rate information on the scaffolds, sustaining the SEM results
and confirming that these structures have adequate struc-
tural properties, such as pore size and pore interconnectiv-
ity present along the scaffold.
SPARC adsorption on scaffolds. SPARC adsorption on scaf-
folds was evaluated by radiolabeling. Residual free 125I
adsorption to the scaffolds surface was found to be about
0.2%, after exposure of this surface to mixtures with different
concentrations of unlabeled SPARC plus labeled free iodide.
This amount is negligible considering that in our solution we
only have ca. 2% free iodide ion, instead of 100%.
The amount of SPARC adsorbed on scaffolds surface was
0.476 0.10 lg/m2 (actual surface area obtained by micro-CT).
In vitro assays
MC3T3-E1 cell line behavior within the scaffolds. Figure
3(A,B) represents the cell metabolic activity of MC3T3-E1
cells when cultured in nanoHA and nanoHA/collagen
scaffolds during 21 days.
The cells present on both scaffolds had an increasing
metabolic activity over time indicating that these constructs
displayed a non-cytotoxic effect and had the ability to sup-
port osteoblast cell adhesion. The normalized results in
graph B provided a better perception of the behavior of
cells in the 3D environment. When comparing 4 h with 21
days, in Figure 3(B), the values for nanoHA increased four-
fold while in nanoHA/collagen increased 3.8-fold.
During the observations of MC3T3-E1 cell distribution
and morphology by CLSM, cells were distributed throughout
the scaffolds and were found at different depths, Figure 4.
At 24 h cells already adopted an osteoblast-like morphology.
The images from 14 days (data not shown) were identical
to the ones from 21 days. Undoubtedly, cells proliferated
over the scaffolds surface, and formed continuous cell layers
contouring the pore walls.
SEM imaging analysis revealed that osteoblasts were
able to attach and spread on the surface of both nanoHA
and nanoHA/collagen constructs, Figure 5. At 24 h of cell
culture, cells exhibit a typical well-spread and spindle-like
morphology and closely bind to the surface through
cytoplasmic extensions away from the cell main body. After
14 days of culture, both types of 3D surfaces were highly
covered by cells and at higher magnifications, a fibrillar
ECM produced from cells was observed, while cellular
secreted products, such as natural apatite, could be identi-
fied mainly at 21 days (black circle). At the later time
points, it became difficult to individually identify cells
due to their higher number, cell-cell contact and partial
overlapping. Herein, cells presented predominantly a flatter
morphology.
PCa cells
PC-3 and LNCaP metabolic activity. PC3 cells were seeded
on the nanoHA and nanoHA/collagen scaffolds with and with-
out the adsorbed SPARC. The metabolic activity of PC-3 cells
cultured on TCPS increased considerably with time, while cell
seeded in scaffolds presented a sustained increase, Figure
6(A). The presence of collagen in unmodified scaffolds or
grafted with SPARC induced an increase of cell metabolic
activity at 1, 2, 4, and 7 days of cell culture.
The cell metabolic activity of LNCaP cells grown in
bone-like constructs clearly decreased along the 21 days,
FIGURE 2. ATR-FTIR spectra of nonsintered nanoHA powder, crosslinked collagen fibers, nanoHA scaffold, and nanoHA/collagen scaffold. The
characteristic peaks of nanoHA and collagen are present. ATR-FTIR spectra magnification of collagen and nanoHA/collagen scaffold samples
between the wavenumber 1800 to 1200 cm21.
FIGURE 3. Metabolic activity of MC3T3-E1 cultured on TCPS, nanoHA, and nanoHA/collagen scaffolds during 21 days, estimated by Alamar
Blue assay. (A) Metabolic activity of MC3T3-E1 expressed in RFU and (B) normalized RFU (%). *Significant difference from nanoHA within the
respective time point (p < 0.05).
FIGURE 4. CLSM fluorescence images of the cell distribution and morphology of MC3T3-E1 in the 3D scaffolds during 21 days of culture. The
cell cytoskeleton is stained in red (Phalloidin 594) and the nucleus in blue (Hoechst). Scale bar: 100 lm.
except for the TCPS as seen in Figure 6(A). These differen-
ces to TCPS are most probably due to the structural differ-
ence between our 3D matrices and the 2D surface of TCPS
onto which cell metabolic activity occurs very intensively
but far from the actual situation in most scaffolds.18,28,29
Other authors have shown behavior of PC3 and LNCaP
cells on decelularized ECM similar to that on TCP but only
in 2D conditions.30 In order to better distinguish differences
between metabolic activity of PCa cells on several scaffolds,
a normalization of data was performed relatively to TCPS.
No statistical differences were found on PC-3 metabolic
activity data when exogeneous SPARC was adsorbed on
biocomposites surfaces [Fig. 6(B)].
As far as LNCaP cells are concerned, the metabolic activ-
ity on the scaffolds without the immobilized SPARC nearly
decreased 100% whereas on the ones functionalized with
SPARC the decrease was around 70%, as seen in Figure
6(B). It can be assumed that LNCaP cells were not able to
normally adhere and colonize the scaffolds, but the presence
of SPARC counteracted this behavior.
PC-3 and LNCaP behavior and morphology within the
scaffolds. Regarding CLSM images analysis (Fig. 7), PC-3 cells
seeded in the scaffolds at 24 h adopted both spherical
(whether, trying to adapt to the new 3D environment or
undergoing cell division) and spindle-like morphology. Fur-
thermore, the cytoskeleton of these cells was more elongated
than on 2D structures, probably due to the presence of many
3D anchoring points at micro and nanopores of the scaffolds.
Indeed, PC-3 cells presented filopodia-like extensions to
probe the surrounding microenvironment as shown in SEM
micrograph (Fig. 8). At day 21, extensive PC-3 cell prolifera-
tion could be observed in the CLSM images (Fig. 7). Cells were
found at different depths and homogeneously distributed
throughout the scaffolds, displaying delineated and elongated
actin filaments along the macropores walls, similarly to an
osteoblastic-like morphology. By SEM images, two cell mor-
phologies were observed on both scaffolds, on one hand most
of the cells displayed a spindle-like morphology and were
completely spread. On the other hand, some round cells were
also found near to elongated cells, some of them starting to
spread with short filopodia. This suggests that spherical cells
were in the process of division, where actin filaments net-
works were contracted, therefore acquiring a round shape.
Some fibrillar ECM was identified on the nanoHA/collagen
scaffolds at 21 days.
LNCaP cells cultured on 2D structures appeared in a
well spread out morphology, while in 3D cultures, cells
adopted a round morphology, and formed various cell
agglomerate colonies (Fig. 7). The SEM micrographs of the
LNCaP seeded scaffolds were helpful to observe that cells
adopted cobblestone morphology. After 21 days of culture,
LNCaP cells assembled in cell clusters merged into highly
compact multilayered masses of cells. Some adherent cells
FIGURE 5. SEM micrographs of cell adhesion and morphology of MC3T3-E1 cells at 14 and 21 days, on nanoHA and nanoHA/collagen scaffolds.
At 14 days fibrillar ECM produced by cells can be observed, and the black circle at 21 days identify deposits of natural apatite produced by cells
(black circle).
were spotted but the great majority was distributed through-
out the scaffolds in spherical aggregates.
SEM and CLSM images corroborates the metabolic activ-
ity values found for the LNCaP cell line, where it can be
observed that in the scaffolds LNCaP cells show a com-
pletely different behavior from the 2D cultures.
DISCUSSION
The PU sponge impregnation method was useful in the pro-
duction of highly porous nanoHA scaffolds. In the slurry
preparation, the Dolapix CE-64 (dispersing agent) provided
a uniform particle size distribution, preventing the over-
aggregation of HA particles and influencing the sintering
quality. It was possible to visualize by SEM that the use of
Dolapix CE-64 improved the scaffold density, where a bal-
ance between density and adequate porosity was achieved.
Porosity ranging from macro to nano scales was present
throughout the scaffolds as observed in Figure 1.
To closely resemble the native bone composition, type I
collagen was adsorbed onto the nanoHA scaffolds. The
collagen concentration of 0.05% appeared to be the most
appropriate to have both biomaterials available to interact
with cells or with other molecules, like proteins. To improve
the resistance toward enzymatic degradation and to
decrease the antigenicity collagen was crosslinked using
EDC/NHS (a noncytotoxic and biocompatible crosslinking
agent).21,31–33
The samples subjected to ATR-FTIR studies confirmed
the purity of the nanoHA scaffold, due to the absence of car-
bonated groups.26 Accordingly, the sintering process did not
modify the nanophased HA powder composition and the
characteristic amide bands of type I collagen were also
present on nanoHA/collagen scaffolds.
Pore interconnectivity makes accessible the passageway
of cells and fluids, in order to ensure cell survival. When
poor molecular diffusion occurs, cells tend to preferentially
exhibit peripheral cellular growth, while in the inner part of
the scaffold cells undergo apoptosis.34 The key parameters
such as high and interconnected porosity, pore size,
adequate topography, and high surface area to volume ratio
are essential to generate uniform cell delivery, assist cellular
adhesion, and neo-tissue formation.35,36 The produced bio-
ceramic scaffolds have a 626 2% macroporosity, fitting
within the acceptable porosity range between 45 and 90%,
to successfully induced bone growth.25,37 Additionally, the
mean pore size of 3676 6 mm obtained was also adequate,
since reported studies identified the pore size ranging
between 200 and 500 mm as most adequate for osteoblast
colonization and new bone matrix deposition.38,39 The mac-
ropore measurements made by SEM were correlated with
the results obtained from the quantitative micro-CT meas-
urements. Other advantageous features were the spherical
topography and the microporosity obtained, providing
anchoring points for cell adhesion.
FIGURE 6. Metabolic activity of PC3 and LNCaP cells cultured in TCPS, nanoHA with and without the SPARC and in nanoHA/collagen scaffolds
with and without SPARC during 21 days, estimated by Alamar Blue assay. (A) Metabolic activity of PC3 and LNCaP expressed in RFU, and (B)
normalized RFU (%) of PC3 and LNCaP. #Significant difference from nanoHA1SPARC within the respective time point. **Significant difference
from nanoHA/collagen within the respective time point. *Significant difference from nanoHA within the respective time point (p < 0.05).
Currently, several attempts are being made to develop-
ing methods of modifying the surfaces of biomaterials to
achieve the desired biologic responses since substrate physi-
cochemical proprieties influence protein adsorption and its
functional activity.14,40,41
SPARC, as a counter-adhesive protein, have multiple
coordinated functions on cell adhesion, motility, and prolif-
eration during bone mineralization and also in cancer devel-
opment and progression. The expression and activity of
SPARC is correlated with metastatic dissemination ability of
PCa cells into bone.12 In fact, the study of such protein on a
3D bone-like model could improve the knowledge of cancer
related bone metastasis. It is already known that SPARC has
a strong affinity toward collagen and hydroxyapatite, thus
leading binding to scaffolds such as those present in this
study.
The amount of adsorbed SPARC on nanoHA/collagen
scaffold surfaces, using radiollabeling 125I-SPARC, was 0.470
mg/m2, higher than the one obtained in a previous work,
where SPARC was adsorbed on nanophased hydroxyapatite
discs (0.190 mg/m2) due to the higher surface area exposed
with multiple binding points.25
The scaffolds induced cell growth and proliferation of
MC3T3-E1 cells. Furthermore, these osteoblasts were able
to produce ECM after 14 days of culture and deposits of
natural apatite secreted by cells were detected mainly at 21
days (Fig. 5).
Two different PCa cell lines (PC3 and LNCaP) were also
cultured in the nanoHA/collagen bone-like scaffolds. The
PC3 behavior was similar to MC3T3-E1 but the colonization
response was lower. PC3 seemed to acquire an “osteoblast-
like” morphology, and this behavior is reported to be nor-
mal due to the highly protective and restricted bone tissue,
where cancerous cells must acquire osteomimetic abilities
in order to survive in the bone microenvironmen.7 Concern-
ing LNCaP cells, these are dependent on external androgens
for growth and, to correlate more closely to the clinical sce-
nario, cells were cultured under an androgen-depleted con-
dition to mimic the system of patients who undergo
androgen deprivation therapy (ADT). The CLSM and SEM
images of LNCaP were consistent, and helped to understand
the metabolic activity results, where the cells underwent
morphogenic changes when in 3D, forming tumor-like
structures with compact multilayered masses, with high
FIGURE 7. CLSM fluorescence images of the cell distribution and morphology of PC3 and LNCaP cells, on the TCPS (2D) and on the 3D nanoHA/
collagen scaffolds at 24 h and 21 days of culture. The cytoskeleton of cells is stained in red (Phalloidin 594) and the nucleus in blue (Hoechst).
Scale bar: 50 lm (in 2D) and 100 lm (in 3D).
possibility of hypoxic and apoptotic cores. Other research
studies have reported a similar cell morphology behavior
when in 3D.14,18,28,29,42
Regarding the tested SPARC concentration of 10 mg/mL,
no differences were identified in terms of PCa cell morphol-
ogy. Yet, the presence of SPARC had a positive influence on
cell metabolic activity of LNCaP cells. Particularly, the meta-
bolic activity values decreased nearly 100% when compar-
ing 4 h with 21 days of culture for both scaffolds without
protein pre-adsorption, whereas both scaffolds with SPARC
pre-adsorbed only decreased 70%, suggesting that SPARC
plays a role in retaining LNCaP cells at the latter time
points. These results are in accordance with a previous
work where the presence of exogenous SPARC contributed
to the survival and significant growth of a non-bone meta-
static PCa cell line (LNCaP) on bone-like construct. The
addition of exogenous SPARC might have compensated for
the expected low SPARC expression levels in LNCaP, provid-
ing a significant advantage growth on a bone-like biomate-
rial through regulation of signaling integrins and interaction
with ECM components.14
Between the three studied cell lines, the MC3T3-E1 was
the one presenting the highest colonization level. PC3 was
expected to have a colonization level very similar to
MC3T3-E1 due to its aggressiveness and its tendency to
metastasize into bone tissue.42,43 The different extraction
sources and different levels of aggressiveness of the two
PCa lines, can also explain the very different behavior and
adaptability between PC3 and LNCaP. Published studies
reported that collagen type I acts as an adhesive substrate
for cancer cells and may influence the retention of meta-
static cells in the skeleton.44 Therefore, a higher metabolic
activity in PC3 and LNCaP was expected in the presence of
collagen. Nevertheless, the production of fibrillar ECM by
PC3 cells was detected at 21 days in the nanoHA/collagen
scaffolds.
In brief, the present results suggest that these scaffolds
were adequate for adsorption of SPARC and cell culture
studies. Moreover, this 3D model may be used as synthetic
bone substitute for small bone defects and in extending the
knowledge of tumor cell biology, not just for PCa but also
for other tumors that similarly metastasize to bone (breast
cancer for instance), which may help to advance PCa clinical
outcomes.
CONCLUSIONS
In prostate cancer, the interactions between cancer cells and
their microenvironment are fundamental to understand the pro-
gression of this pathology. Accordingly, a 3D model for in vitro
studies that would approach a tumor microenvironment in bone
FIGURE 8. SEM micrographs of the nanoHA/collagen cell-seeded scaffolds of PC3 and LNCaP cells after 24 h and 21 days. Top right image dis-
plays a region with ECM produced by PC3 cells.
was designed. These scaffolds were capable of providing a 3D
support for adhesion and colonization of both MC3T3-E1 and
PC3 cells. On the other hand, a different cell behavior was
observed with the LNCaP cell line that derives from a non-bone
metastatic site, in which cells grew as clusters. Few studies are
reported using 3D biomaterials to culture PCa cells, therefore
this line of work represents a novel type of study for the under-
standing of cancer biology. The versatility of these 3D models
offers great opportunities to study cancers that metastasize pri-
marily to bone. Hopefully, this will ultimately benefit the devel-
opment of cancer therapies.
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